This is an aggregated industry headline. Read the full story at Drug Channels →
Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI's 2026 Update (rerun)
This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders. Click here to see the original post from April 2026. By Adam J. Fein, Ph.D.It's time for Drug Channels Institute's (DCI) a
By Drug Channels
· Jun 10, 2026
· via Drug Channels
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Nominate up-and-coming early-career pharma marketing pros here to be featured in Fierce's "Rising Stars" Q&…
The WeekFierceBiotech ↗
AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese bi…
The WeekBriefing
The FDA posted an updated list of all approved ANDAs with Competitive Generic Therapy designation, including e…